Cooke Julie bought NBIX
June 2, 2026 · Form 4 insider transaction
Cooke Julie bought 24,965 shares of Neurocrine Biosciences, Inc. at $81.49 per share, a transaction worth $2.03M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,965
Price
$81.49
Total value
$2.03M
InsiderCooke Julie
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 2, 2026
Filing dateJune 4, 2026
Shares owned after59,311
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes an aggregate of 176 shares purchased on February 27, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.